サルコペニア(Sarcopenia):治療薬開発パイプライン動向2018

調査会社DelveInsight社が発行したリサーチレポート(データ管理コード:DIPR2016593)
◆英語タイトル:Sarcopenia-Pipeline Insights, 2018
◆発行会社/調査会社:DelveInsight
◆商品コード:DIPR2016593
◆発行日:2018年11月
◆調査対象地域:グローバル
◆産業分野:製薬
◆ページ数:約60
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール(受注後3営業日)
◆販売価格オプション(消費税別)
Single User(1名使用)USD1,250 ⇒換算¥141,250見積依頼/購入/質問フォーム
Site Price(同一国内共有可)USD2,500 ⇒換算¥282,500見積依頼/購入/質問フォーム
Enterprise Price(複数国内共有可)USD4,000 ⇒換算¥452,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
DelveInsight社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[サルコペニア(Sarcopenia):治療薬開発パイプライン動向2018]についてメールでお問い合わせはこちら
※本調査レポートでは、世界におけるサルコペニア(Sarcopenia)の治療薬開発パイプライン動向について調査・分析し、企業別開発中の治療薬、各臨床試験段階における製品リスト及び比較分析、薬剤候補のプロファイル、治療薬の評価、開発中止又は開発休止中の薬剤リスト等をお届けしています。また、サルコペニア(Sarcopenia)治療薬開発に取り組んでいる企業情報も提供しています。

・サルコペニア(Sarcopenia)の概要

・サルコペニア(Sarcopenia)の治療薬パイプライン概要

・企業別開発中のサルコペニア(Sarcopenia)治療薬

・後期治験段階の薬剤(Filed & Phase III):比較分析

・中期治験段階の薬剤(Phase II):比較分析

・初期治験段階の薬剤(Phase I & IND Filed):比較分析

・前臨床段階の薬剤:比較分析

・薬剤候補のプロファイル

・サルコペニア(Sarcopenia)治療薬の評価
  - 単剤治療薬別評価
  - 併用治療薬別評価
  - 投与経路別評価
  - 分子種類別評価

・開発が中止された薬剤リスト

・開発休止中の薬剤リスト

・サルコペニア(Sarcopenia)治療薬開発に取り組んでいる企業リスト

・図表一覧
*** レポート概要(サマリー)***

SUMMARY
DelveInsight’s, “ Sarcopenia-Pipeline Insights, 2018”, report provides in depth insights on the pipeline drugs and their development activities around the Sarcopenia. The DelveInsight’sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. DelveInsight’s Report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Sarcopenia. DelveInsight’s Report also assesses the Sarcopenia therapeutics by Monotherapy, Combination products, Molecule type and Route of Administration.

Please note:This report requires certain updates. We have all the information available but require 3 business days to complete the process and ensure it is as up-to-date as possible. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated indication.


Scope
• The report provides competitivepipeline landscape of Sarcopenia
• The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information
• Coverage of the Sarcopenia pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
• The report reviews key players involved in the therapeutics development for Sarcopenia and also provide company profiling
• The report also gives the information of dormant and discontinued pipeline projects
• Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages
• Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type


*** レポート目次(コンテンツ)***

Table of Contents
• Sarcopenia Overview
• Sarcopenia Pipeline Therapeutics
• Sarcopenia Therapeutics under Development by Companies
• Sarcopenia Filed and Phase III Products
• Comparative Analysis
• Sarcopenia Phase II Products
• Comparative Analysis
• Sarcopenia Phase I and IND Filed Products
• Comparative Analysis
• Sarcopenia Discovery and Pre-Clinical Stage Products
• Comparative Analysis
• Drug Candidate Profiles
• Sarcopenia – Therapeutics Assessment
• Assessment by Monotherapy Products
• Assessment by Combination Products
• Assessment by Route of Administration
• Assessment by Molecule Type
• Sarcopenia – Discontinued Products
• Sarcopenia – Dormant Products
• Companies Involved in Therapeutics Development for Sarcopenia
• Appendix
• Methodology
• Contact Us
• Disclaimer

List of Tables
• Number of Products under Development for Sarcopenia, 2018
• Number of Products under Development by Companies
• Comparative Analysis by Filed and Phase III Products, 2018
• Comparative Analysis Phase II Products, 2018
• Comparative Analysis Phase I and IND Filed Products, 2018
• Comparative Analysis Discovery and Pre-Clinical Stage Products, 2018
• Drug Candidates Profiles
• Sarcopenia Assessment by Monotherapy Products
• Sarcopenia Assessment by Combination Products
• Sarcopenia Assessment by Route of Administration
• Sarcopenia Assessment by Stage and Route of Administration
• Sarcopenia Assessment by Molecule Type
• Sarcopenia Assessment by Stage and Molecule Type
• Sarcopenia Therapeutics – Discontinued Products
• Sarcopenia Therapeutics – Dormant Products
• Products under Development by Companies, 2018


List of Figures
• Number of Products under Development for Sarcopenia, 2018
• Filed and Phase III Products, 2018
• Phase II Products, 2018
• Phase I and IND Filed Products, 2018
• Discovery and Pre-Clinical Stage Products, 2018
• Sarcopenia Assessment by Monotherapy Products
• Sarcopenia Assessment by Combination Products
• Sarcopenia Assessment by Route of Administration
• Sarcopenia Assessment by Stage and Route of Administration
• Sarcopenia Assessment by Molecule Type
• Sarcopenia Assessment by Stage and Molecule Type


*** レポートのキーワード ***

サルコペニア(Sarcopenia)、治療薬、医薬品、薬剤、製薬企業、研究開発、治験、パイプライン

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
  • 世界の個人用ビジネス文房具市場2017
    Personalized Business Stationery Report by Material, Application, and Geography – Global Forecast to 2021 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (Unit …
  • Alimta:医薬品の世界市場規模、市販状況、特許、APIメーカー分析2015
    Summary DelveInsight’s, Alimta-API Insights, 2015,report provides Alimta marketed details and API Manufacturers details across the globe along with the location. DelveInsight’s report gives the clear idea on the United States Drug Master File (USDMF) and Europe DMF filed by worldwide countries relat …
  • エチレンオキサイド付加重合体の世界市場2018
    Ethylene Oxide Addition Polymer Report by Material, Application, and Geography – Global Forecast to 2022 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (Unite …
  • 飼料添加剤の世界市場予測(~2022年)
    “Feed additives market is projected to grow at a CAGR of 4.5% during the forecast period.”The feed additives market is estimated at USD 22.62 billion in 2017 and is projected to grow at a CAGR of 4.5%, to reach USD 28.22 billion by 2022. The main factors that drive the demand for feed additives incl …
  • 中国の楽器産業プロフィール(China Musical Instruments Industry Profile – ISIC3692)
    Provides key data and concise analyses, presents a comparative analysis on the development of musical instruments industry in 31 provincial regions and 20 major cities in visualized form of data map. The report also includes a list of major 100 enterprises in the sector and the comparison on investm …
  • Intefen:医薬品の世界市場2016
    DelveInsight Drug Report, “Intefen- Drug Insights, 2016” highlights the Intefen marketed details, pipeline status and the Global API Manufacturers along with the location. The DelveInsight’s report covers the Global Market Assessment of the Intefen covering the total sales estimation and also provid …
  • くん製魚の世界市場:販売動向2017
    Notes:Sales, means the sales volume of Smoked Fish Revenue, means the sales value of Smoked Fish This report studies sales (consumption) of Smoked Fish in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenu …
  • Japan Airlines Co., Ltd. (9201):企業概要・SWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "Japan Airlines Co., Ltd." The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. World Market Intel …
  • 世界のIndustrial Enzymes市場動向(2012-2016)
    TechNavio's analysts forecast the Global Industrial Enzymes market to grow at a CAGR of 7.49 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increase in the end-user applications of industrial enzymes. The Global Industrial Enzymes market has also …
  • 世界のボトルウォーター市場
    The global bottled industry is one of the fastest expanding industries in today’s time. World bottled water market is expected to reach $70 billion by 2017 and will be stimulated by rising population, consumer spending patterns, lifestyle trends and growing levels of health consciousness, among othe …
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(DIPR2016593 )"サルコペニア(Sarcopenia):治療薬開発パイプライン動向2018" (英文:Sarcopenia-Pipeline Insights, 2018)はDelveInsight社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。